
Pharma Pulse 2/10/25: How 2025 Will Reshape Patient Support, ‘Food is Medicine’ & more
The latest news for pharma industry insiders.
2024 was a pivotal year for the patient support landscape, as the space underwent a substantial shift shaped by market dynamics, regulatory changes, and the evolving needs of patients.
After a quarter marked by intense discussions at industry conferences and candid conversations with pharmaceutical leaders grappling with unprecedented change, one thing is clear: 2025 will fundamentally transform how drugs are covered, paid for, and filled in America.
The food is medicine concept is wide-ranging, from specifically made, medically tailored meals to produce prescriptions to nutrition security programs such as the Supplemental Nutrition Assistance Program. One problem for payers — whether government programs, private insurers or philanthropies — is ensuring that the program provides nutritious and appropriate foods. What’s missing from this equation is standards.
Companies are investing heavily in AI without seeing real productivity gains. What are workers doing with time saved using new AI tools?
Cencora has expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with reliable access to critical medications, including those at risk of going on shortage. Nearly 200 medications — including several oncology treatments — are now available through the program, which represents an increase of more than 350% since the program launched in 2021.
Thanks for having me. Always a pleasure to speak with Mike.
Have news you want us to share in Pharma Pulse? Reach out to Editor
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





